Global Nucleic Acid Multiplex Assay Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Nucleic Acid Multiplex Assay market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Nucleic Acid Multiplex Assay market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nucleic Acid Multiplex Assay market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nucleic Acid Multiplex Assay
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nucleic Acid Multiplex Assay market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US) and Qiagen N.V. (Netherlands), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Nucleic Acid Multiplex Assay market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Nucleic Acid Multiplex Assay product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acid Multiplex Assay, with revenue, gross margin and global market share of Nucleic Acid Multiplex Assay from 2018 to 2023.
Chapter 3, the Nucleic Acid Multiplex Assay competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nucleic Acid Multiplex Assay market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acid Multiplex Assay.
Chapter 13, to describe Nucleic Acid Multiplex Assay research findings and conclusion.
This report is a detailed and comprehensive analysis for global Nucleic Acid Multiplex Assay market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nucleic Acid Multiplex Assay market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nucleic Acid Multiplex Assay market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nucleic Acid Multiplex Assay
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nucleic Acid Multiplex Assay market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US) and Qiagen N.V. (Netherlands), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Nucleic Acid Multiplex Assay market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Planar Nucleic Acid Assays
- Bead-Based Nucleic Acid Assays
- Other Nucleic Acid Assays
- Pharmaceutical & Biotechnology Companies
- Hospitals & Research Institutes
- Reference Laboratories
- Other
- Luminex Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- Illumina, Inc (US)
- Bio-Rad Laboratories, Inc. (US)
- Qiagen N.V. (Netherlands)
- Abcam plc (UK)
- Becton, Dickinson and Company (US)
- Merck KGaA (Germany)
- Agilent Technologies, Inc. (US)
- Meso Scale Diagnostics (US)
- Randox Laboratories (UK)
- Quanterix (US)
- Bio-Techne Corporation (US)
- Olink (Sweden)
- DiaSorin S.p.A. (Italy)
- Seegene (South Korea)
- Promega Corporation (US)
- Siemens Healthineers (Germany)
- PerkinElmer, Inc. (US)
- Shimadzu Biotech (Japan)
- Antigenix America, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Boster Biological Technology (US)
- AYOXXA Biosystems GmbH (Germany)
- Cayman Chemical Company (US)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Nucleic Acid Multiplex Assay product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acid Multiplex Assay, with revenue, gross margin and global market share of Nucleic Acid Multiplex Assay from 2018 to 2023.
Chapter 3, the Nucleic Acid Multiplex Assay competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nucleic Acid Multiplex Assay market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acid Multiplex Assay.
Chapter 13, to describe Nucleic Acid Multiplex Assay research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Nucleic Acid Multiplex Assay
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acid Multiplex Assay by Type
1.3.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Type in 2022
1.3.3 Planar Nucleic Acid Assays
1.3.4 Bead-Based Nucleic Acid Assays
1.3.5 Other Nucleic Acid Assays
1.4 Global Nucleic Acid Multiplex Assay Market by Application
1.4.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Hospitals & Research Institutes
1.4.4 Reference Laboratories
1.4.5 Other
1.5 Global Nucleic Acid Multiplex Assay Market Size & Forecast
1.6 Global Nucleic Acid Multiplex Assay Market Size and Forecast by Region
1.6.1 Global Nucleic Acid Multiplex Assay Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nucleic Acid Multiplex Assay Market Size by Region, (2018-2029)
1.6.3 North America Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.4 Europe Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.6 South America Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Luminex Corporation (US)
2.1.1 Luminex Corporation (US) Details
2.1.2 Luminex Corporation (US) Major Business
2.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.1.4 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Luminex Corporation (US) Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc. (US)
2.2.1 Thermo Fisher Scientific Inc. (US) Details
2.2.2 Thermo Fisher Scientific Inc. (US) Major Business
2.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.2.4 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Inc. (US) Recent Developments and Future Plans
2.3 Illumina, Inc (US)
2.3.1 Illumina, Inc (US) Details
2.3.2 Illumina, Inc (US) Major Business
2.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product and Solutions
2.3.4 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina, Inc (US) Recent Developments and Future Plans
2.4 Bio-Rad Laboratories, Inc. (US)
2.4.1 Bio-Rad Laboratories, Inc. (US) Details
2.4.2 Bio-Rad Laboratories, Inc. (US) Major Business
2.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.4.4 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bio-Rad Laboratories, Inc. (US) Recent Developments and Future Plans
2.5 Qiagen N.V. (Netherlands)
2.5.1 Qiagen N.V. (Netherlands) Details
2.5.2 Qiagen N.V. (Netherlands) Major Business
2.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product and Solutions
2.5.4 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Qiagen N.V. (Netherlands) Recent Developments and Future Plans
2.6 Abcam plc (UK)
2.6.1 Abcam plc (UK) Details
2.6.2 Abcam plc (UK) Major Business
2.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.6.4 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abcam plc (UK) Recent Developments and Future Plans
2.7 Becton, Dickinson and Company (US)
2.7.1 Becton, Dickinson and Company (US) Details
2.7.2 Becton, Dickinson and Company (US) Major Business
2.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.7.4 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Becton, Dickinson and Company (US) Recent Developments and Future Plans
2.8 Merck KGaA (Germany)
2.8.1 Merck KGaA (Germany) Details
2.8.2 Merck KGaA (Germany) Major Business
2.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.8.4 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck KGaA (Germany) Recent Developments and Future Plans
2.9 Agilent Technologies, Inc. (US)
2.9.1 Agilent Technologies, Inc. (US) Details
2.9.2 Agilent Technologies, Inc. (US) Major Business
2.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.9.4 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies, Inc. (US) Recent Developments and Future Plans
2.10 Meso Scale Diagnostics (US)
2.10.1 Meso Scale Diagnostics (US) Details
2.10.2 Meso Scale Diagnostics (US) Major Business
2.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product and Solutions
2.10.4 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Meso Scale Diagnostics (US) Recent Developments and Future Plans
2.11 Randox Laboratories (UK)
2.11.1 Randox Laboratories (UK) Details
2.11.2 Randox Laboratories (UK) Major Business
2.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.11.4 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Randox Laboratories (UK) Recent Developments and Future Plans
2.12 Quanterix (US)
2.12.1 Quanterix (US) Details
2.12.2 Quanterix (US) Major Business
2.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Product and Solutions
2.12.4 Quanterix (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Quanterix (US) Recent Developments and Future Plans
2.13 Bio-Techne Corporation (US)
2.13.1 Bio-Techne Corporation (US) Details
2.13.2 Bio-Techne Corporation (US) Major Business
2.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.13.4 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Techne Corporation (US) Recent Developments and Future Plans
2.14 Olink (Sweden)
2.14.1 Olink (Sweden) Details
2.14.2 Olink (Sweden) Major Business
2.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Product and Solutions
2.14.4 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Olink (Sweden) Recent Developments and Future Plans
2.15 DiaSorin S.p.A. (Italy)
2.15.1 DiaSorin S.p.A. (Italy) Details
2.15.2 DiaSorin S.p.A. (Italy) Major Business
2.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product and Solutions
2.15.4 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 DiaSorin S.p.A. (Italy) Recent Developments and Future Plans
2.16 Seegene (South Korea)
2.16.1 Seegene (South Korea) Details
2.16.2 Seegene (South Korea) Major Business
2.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Product and Solutions
2.16.4 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Seegene (South Korea) Recent Developments and Future Plans
2.17 Promega Corporation (US)
2.17.1 Promega Corporation (US) Details
2.17.2 Promega Corporation (US) Major Business
2.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.17.4 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Promega Corporation (US) Recent Developments and Future Plans
2.18 Siemens Healthineers (Germany)
2.18.1 Siemens Healthineers (Germany) Details
2.18.2 Siemens Healthineers (Germany) Major Business
2.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.18.4 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Siemens Healthineers (Germany) Recent Developments and Future Plans
2.19 PerkinElmer, Inc. (US)
2.19.1 PerkinElmer, Inc. (US) Details
2.19.2 PerkinElmer, Inc. (US) Major Business
2.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.19.4 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 PerkinElmer, Inc. (US) Recent Developments and Future Plans
2.20 Shimadzu Biotech (Japan)
2.20.1 Shimadzu Biotech (Japan) Details
2.20.2 Shimadzu Biotech (Japan) Major Business
2.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product and Solutions
2.20.4 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Shimadzu Biotech (Japan) Recent Developments and Future Plans
2.21 Antigenix America, Inc. (US)
2.21.1 Antigenix America, Inc. (US) Details
2.21.2 Antigenix America, Inc. (US) Major Business
2.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.21.4 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Antigenix America, Inc. (US) Recent Developments and Future Plans
2.22 Enzo Life Sciences, Inc. (US)
2.22.1 Enzo Life Sciences, Inc. (US) Details
2.22.2 Enzo Life Sciences, Inc. (US) Major Business
2.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.22.4 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Enzo Life Sciences, Inc. (US) Recent Developments and Future Plans
2.23 Boster Biological Technology (US)
2.23.1 Boster Biological Technology (US) Details
2.23.2 Boster Biological Technology (US) Major Business
2.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product and Solutions
2.23.4 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Boster Biological Technology (US) Recent Developments and Future Plans
2.24 AYOXXA Biosystems GmbH (Germany)
2.24.1 AYOXXA Biosystems GmbH (Germany) Details
2.24.2 AYOXXA Biosystems GmbH (Germany) Major Business
2.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.24.4 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 AYOXXA Biosystems GmbH (Germany) Recent Developments and Future Plans
2.25 Cayman Chemical Company (US)
2.25.1 Cayman Chemical Company (US) Details
2.25.2 Cayman Chemical Company (US) Major Business
2.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.25.4 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Cayman Chemical Company (US) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nucleic Acid Multiplex Assay Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nucleic Acid Multiplex Assay by Company Revenue
3.2.2 Top 3 Nucleic Acid Multiplex Assay Players Market Share in 2022
3.2.3 Top 6 Nucleic Acid Multiplex Assay Players Market Share in 2022
3.3 Nucleic Acid Multiplex Assay Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acid Multiplex Assay Market: Region Footprint
3.3.2 Nucleic Acid Multiplex Assay Market: Company Product Type Footprint
3.3.3 Nucleic Acid Multiplex Assay Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nucleic Acid Multiplex Assay Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nucleic Acid Multiplex Assay Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2023)
5.2 Global Nucleic Acid Multiplex Assay Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
6.2 North America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country
6.3.1 North America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
6.3.2 United States Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
6.3.3 Canada Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
6.3.4 Mexico Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
7.2 Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country
7.3.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
7.3.2 Germany Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.3 France Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.5 Russia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.6 Italy Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region
8.3.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2029)
8.3.2 China Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.3 Japan Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.4 South Korea Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.5 India Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.7 Australia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
9.2 South America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
9.3 South America Nucleic Acid Multiplex Assay Market Size by Country
9.3.1 South America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
9.3.2 Brazil Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
9.3.3 Argentina Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country
10.3.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
10.3.2 Turkey Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10.3.4 UAE Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Nucleic Acid Multiplex Assay Market Drivers
11.2 Nucleic Acid Multiplex Assay Market Restraints
11.3 Nucleic Acid Multiplex Assay Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Nucleic Acid Multiplex Assay Industry Chain
12.2 Nucleic Acid Multiplex Assay Upstream Analysis
12.3 Nucleic Acid Multiplex Assay Midstream Analysis
12.4 Nucleic Acid Multiplex Assay Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Nucleic Acid Multiplex Assay
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acid Multiplex Assay by Type
1.3.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Type in 2022
1.3.3 Planar Nucleic Acid Assays
1.3.4 Bead-Based Nucleic Acid Assays
1.3.5 Other Nucleic Acid Assays
1.4 Global Nucleic Acid Multiplex Assay Market by Application
1.4.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Hospitals & Research Institutes
1.4.4 Reference Laboratories
1.4.5 Other
1.5 Global Nucleic Acid Multiplex Assay Market Size & Forecast
1.6 Global Nucleic Acid Multiplex Assay Market Size and Forecast by Region
1.6.1 Global Nucleic Acid Multiplex Assay Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nucleic Acid Multiplex Assay Market Size by Region, (2018-2029)
1.6.3 North America Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.4 Europe Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.6 South America Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nucleic Acid Multiplex Assay Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Luminex Corporation (US)
2.1.1 Luminex Corporation (US) Details
2.1.2 Luminex Corporation (US) Major Business
2.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.1.4 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Luminex Corporation (US) Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc. (US)
2.2.1 Thermo Fisher Scientific Inc. (US) Details
2.2.2 Thermo Fisher Scientific Inc. (US) Major Business
2.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.2.4 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Inc. (US) Recent Developments and Future Plans
2.3 Illumina, Inc (US)
2.3.1 Illumina, Inc (US) Details
2.3.2 Illumina, Inc (US) Major Business
2.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product and Solutions
2.3.4 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina, Inc (US) Recent Developments and Future Plans
2.4 Bio-Rad Laboratories, Inc. (US)
2.4.1 Bio-Rad Laboratories, Inc. (US) Details
2.4.2 Bio-Rad Laboratories, Inc. (US) Major Business
2.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.4.4 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bio-Rad Laboratories, Inc. (US) Recent Developments and Future Plans
2.5 Qiagen N.V. (Netherlands)
2.5.1 Qiagen N.V. (Netherlands) Details
2.5.2 Qiagen N.V. (Netherlands) Major Business
2.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product and Solutions
2.5.4 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Qiagen N.V. (Netherlands) Recent Developments and Future Plans
2.6 Abcam plc (UK)
2.6.1 Abcam plc (UK) Details
2.6.2 Abcam plc (UK) Major Business
2.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.6.4 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abcam plc (UK) Recent Developments and Future Plans
2.7 Becton, Dickinson and Company (US)
2.7.1 Becton, Dickinson and Company (US) Details
2.7.2 Becton, Dickinson and Company (US) Major Business
2.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.7.4 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Becton, Dickinson and Company (US) Recent Developments and Future Plans
2.8 Merck KGaA (Germany)
2.8.1 Merck KGaA (Germany) Details
2.8.2 Merck KGaA (Germany) Major Business
2.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.8.4 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck KGaA (Germany) Recent Developments and Future Plans
2.9 Agilent Technologies, Inc. (US)
2.9.1 Agilent Technologies, Inc. (US) Details
2.9.2 Agilent Technologies, Inc. (US) Major Business
2.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.9.4 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies, Inc. (US) Recent Developments and Future Plans
2.10 Meso Scale Diagnostics (US)
2.10.1 Meso Scale Diagnostics (US) Details
2.10.2 Meso Scale Diagnostics (US) Major Business
2.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product and Solutions
2.10.4 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Meso Scale Diagnostics (US) Recent Developments and Future Plans
2.11 Randox Laboratories (UK)
2.11.1 Randox Laboratories (UK) Details
2.11.2 Randox Laboratories (UK) Major Business
2.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.11.4 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Randox Laboratories (UK) Recent Developments and Future Plans
2.12 Quanterix (US)
2.12.1 Quanterix (US) Details
2.12.2 Quanterix (US) Major Business
2.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Product and Solutions
2.12.4 Quanterix (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Quanterix (US) Recent Developments and Future Plans
2.13 Bio-Techne Corporation (US)
2.13.1 Bio-Techne Corporation (US) Details
2.13.2 Bio-Techne Corporation (US) Major Business
2.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.13.4 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Techne Corporation (US) Recent Developments and Future Plans
2.14 Olink (Sweden)
2.14.1 Olink (Sweden) Details
2.14.2 Olink (Sweden) Major Business
2.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Product and Solutions
2.14.4 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Olink (Sweden) Recent Developments and Future Plans
2.15 DiaSorin S.p.A. (Italy)
2.15.1 DiaSorin S.p.A. (Italy) Details
2.15.2 DiaSorin S.p.A. (Italy) Major Business
2.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product and Solutions
2.15.4 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 DiaSorin S.p.A. (Italy) Recent Developments and Future Plans
2.16 Seegene (South Korea)
2.16.1 Seegene (South Korea) Details
2.16.2 Seegene (South Korea) Major Business
2.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Product and Solutions
2.16.4 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Seegene (South Korea) Recent Developments and Future Plans
2.17 Promega Corporation (US)
2.17.1 Promega Corporation (US) Details
2.17.2 Promega Corporation (US) Major Business
2.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.17.4 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Promega Corporation (US) Recent Developments and Future Plans
2.18 Siemens Healthineers (Germany)
2.18.1 Siemens Healthineers (Germany) Details
2.18.2 Siemens Healthineers (Germany) Major Business
2.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.18.4 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Siemens Healthineers (Germany) Recent Developments and Future Plans
2.19 PerkinElmer, Inc. (US)
2.19.1 PerkinElmer, Inc. (US) Details
2.19.2 PerkinElmer, Inc. (US) Major Business
2.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.19.4 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 PerkinElmer, Inc. (US) Recent Developments and Future Plans
2.20 Shimadzu Biotech (Japan)
2.20.1 Shimadzu Biotech (Japan) Details
2.20.2 Shimadzu Biotech (Japan) Major Business
2.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product and Solutions
2.20.4 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Shimadzu Biotech (Japan) Recent Developments and Future Plans
2.21 Antigenix America, Inc. (US)
2.21.1 Antigenix America, Inc. (US) Details
2.21.2 Antigenix America, Inc. (US) Major Business
2.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.21.4 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Antigenix America, Inc. (US) Recent Developments and Future Plans
2.22 Enzo Life Sciences, Inc. (US)
2.22.1 Enzo Life Sciences, Inc. (US) Details
2.22.2 Enzo Life Sciences, Inc. (US) Major Business
2.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.22.4 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Enzo Life Sciences, Inc. (US) Recent Developments and Future Plans
2.23 Boster Biological Technology (US)
2.23.1 Boster Biological Technology (US) Details
2.23.2 Boster Biological Technology (US) Major Business
2.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product and Solutions
2.23.4 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Boster Biological Technology (US) Recent Developments and Future Plans
2.24 AYOXXA Biosystems GmbH (Germany)
2.24.1 AYOXXA Biosystems GmbH (Germany) Details
2.24.2 AYOXXA Biosystems GmbH (Germany) Major Business
2.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.24.4 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 AYOXXA Biosystems GmbH (Germany) Recent Developments and Future Plans
2.25 Cayman Chemical Company (US)
2.25.1 Cayman Chemical Company (US) Details
2.25.2 Cayman Chemical Company (US) Major Business
2.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.25.4 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Cayman Chemical Company (US) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nucleic Acid Multiplex Assay Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nucleic Acid Multiplex Assay by Company Revenue
3.2.2 Top 3 Nucleic Acid Multiplex Assay Players Market Share in 2022
3.2.3 Top 6 Nucleic Acid Multiplex Assay Players Market Share in 2022
3.3 Nucleic Acid Multiplex Assay Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acid Multiplex Assay Market: Region Footprint
3.3.2 Nucleic Acid Multiplex Assay Market: Company Product Type Footprint
3.3.3 Nucleic Acid Multiplex Assay Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nucleic Acid Multiplex Assay Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nucleic Acid Multiplex Assay Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2023)
5.2 Global Nucleic Acid Multiplex Assay Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
6.2 North America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country
6.3.1 North America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
6.3.2 United States Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
6.3.3 Canada Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
6.3.4 Mexico Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
7.2 Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country
7.3.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
7.3.2 Germany Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.3 France Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.5 Russia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
7.3.6 Italy Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region
8.3.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2029)
8.3.2 China Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.3 Japan Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.4 South Korea Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.5 India Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
8.3.7 Australia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
9.2 South America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
9.3 South America Nucleic Acid Multiplex Assay Market Size by Country
9.3.1 South America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
9.3.2 Brazil Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
9.3.3 Argentina Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country
10.3.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2029)
10.3.2 Turkey Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
10.3.4 UAE Nucleic Acid Multiplex Assay Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Nucleic Acid Multiplex Assay Market Drivers
11.2 Nucleic Acid Multiplex Assay Market Restraints
11.3 Nucleic Acid Multiplex Assay Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Nucleic Acid Multiplex Assay Industry Chain
12.2 Nucleic Acid Multiplex Assay Upstream Analysis
12.3 Nucleic Acid Multiplex Assay Midstream Analysis
12.4 Nucleic Acid Multiplex Assay Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nucleic Acid Multiplex Assay Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Nucleic Acid Multiplex Assay Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Luminex Corporation (US) Company Information, Head Office, and Major Competitors
Table 6. Luminex Corporation (US) Major Business
Table 7. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 8. Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Luminex Corporation (US) Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Inc. (US) Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc. (US) Major Business
Table 12. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 13. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Thermo Fisher Scientific Inc. (US) Recent Developments and Future Plans
Table 15. Illumina, Inc (US) Company Information, Head Office, and Major Competitors
Table 16. Illumina, Inc (US) Major Business
Table 17. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 18. Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina, Inc (US) Recent Developments and Future Plans
Table 20. Bio-Rad Laboratories, Inc. (US) Company Information, Head Office, and Major Competitors
Table 21. Bio-Rad Laboratories, Inc. (US) Major Business
Table 22. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 23. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bio-Rad Laboratories, Inc. (US) Recent Developments and Future Plans
Table 25. Qiagen N.V. (Netherlands) Company Information, Head Office, and Major Competitors
Table 26. Qiagen N.V. (Netherlands) Major Business
Table 27. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product and Solutions
Table 28. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Qiagen N.V. (Netherlands) Recent Developments and Future Plans
Table 30. Abcam plc (UK) Company Information, Head Office, and Major Competitors
Table 31. Abcam plc (UK) Major Business
Table 32. Abcam plc (UK) Nucleic Acid Multiplex Assay Product and Solutions
Table 33. Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Abcam plc (UK) Recent Developments and Future Plans
Table 35. Becton, Dickinson and Company (US) Company Information, Head Office, and Major Competitors
Table 36. Becton, Dickinson and Company (US) Major Business
Table 37. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 38. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Becton, Dickinson and Company (US) Recent Developments and Future Plans
Table 40. Merck KGaA (Germany) Company Information, Head Office, and Major Competitors
Table 41. Merck KGaA (Germany) Major Business
Table 42. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 43. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck KGaA (Germany) Recent Developments and Future Plans
Table 45. Agilent Technologies, Inc. (US) Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies, Inc. (US) Major Business
Table 47. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 48. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies, Inc. (US) Recent Developments and Future Plans
Table 50. Meso Scale Diagnostics (US) Company Information, Head Office, and Major Competitors
Table 51. Meso Scale Diagnostics (US) Major Business
Table 52. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 53. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Meso Scale Diagnostics (US) Recent Developments and Future Plans
Table 55. Randox Laboratories (UK) Company Information, Head Office, and Major Competitors
Table 56. Randox Laboratories (UK) Major Business
Table 57. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product and Solutions
Table 58. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Randox Laboratories (UK) Recent Developments and Future Plans
Table 60. Quanterix (US) Company Information, Head Office, and Major Competitors
Table 61. Quanterix (US) Major Business
Table 62. Quanterix (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 63. Quanterix (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Quanterix (US) Recent Developments and Future Plans
Table 65. Bio-Techne Corporation (US) Company Information, Head Office, and Major Competitors
Table 66. Bio-Techne Corporation (US) Major Business
Table 67. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 68. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Bio-Techne Corporation (US) Recent Developments and Future Plans
Table 70. Olink (Sweden) Company Information, Head Office, and Major Competitors
Table 71. Olink (Sweden) Major Business
Table 72. Olink (Sweden) Nucleic Acid Multiplex Assay Product and Solutions
Table 73. Olink (Sweden) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Olink (Sweden) Recent Developments and Future Plans
Table 75. DiaSorin S.p.A. (Italy) Company Information, Head Office, and Major Competitors
Table 76. DiaSorin S.p.A. (Italy) Major Business
Table 77. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product and Solutions
Table 78. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. DiaSorin S.p.A. (Italy) Recent Developments and Future Plans
Table 80. Seegene (South Korea) Company Information, Head Office, and Major Competitors
Table 81. Seegene (South Korea) Major Business
Table 82. Seegene (South Korea) Nucleic Acid Multiplex Assay Product and Solutions
Table 83. Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Seegene (South Korea) Recent Developments and Future Plans
Table 85. Promega Corporation (US) Company Information, Head Office, and Major Competitors
Table 86. Promega Corporation (US) Major Business
Table 87. Promega Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 88. Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Promega Corporation (US) Recent Developments and Future Plans
Table 90. Siemens Healthineers (Germany) Company Information, Head Office, and Major Competitors
Table 91. Siemens Healthineers (Germany) Major Business
Table 92. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 93. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Siemens Healthineers (Germany) Recent Developments and Future Plans
Table 95. PerkinElmer, Inc. (US) Company Information, Head Office, and Major Competitors
Table 96. PerkinElmer, Inc. (US) Major Business
Table 97. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 98. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. PerkinElmer, Inc. (US) Recent Developments and Future Plans
Table 100. Shimadzu Biotech (Japan) Company Information, Head Office, and Major Competitors
Table 101. Shimadzu Biotech (Japan) Major Business
Table 102. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product and Solutions
Table 103. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Shimadzu Biotech (Japan) Recent Developments and Future Plans
Table 105. Antigenix America, Inc. (US) Company Information, Head Office, and Major Competitors
Table 106. Antigenix America, Inc. (US) Major Business
Table 107. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 108. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Antigenix America, Inc. (US) Recent Developments and Future Plans
Table 110. Enzo Life Sciences, Inc. (US) Company Information, Head Office, and Major Competitors
Table 111. Enzo Life Sciences, Inc. (US) Major Business
Table 112. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 113. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Enzo Life Sciences, Inc. (US) Recent Developments and Future Plans
Table 115. Boster Biological Technology (US) Company Information, Head Office, and Major Competitors
Table 116. Boster Biological Technology (US) Major Business
Table 117. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 118. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boster Biological Technology (US) Recent Developments and Future Plans
Table 120. AYOXXA Biosystems GmbH (Germany) Company Information, Head Office, and Major Competitors
Table 121. AYOXXA Biosystems GmbH (Germany) Major Business
Table 122. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 123. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. AYOXXA Biosystems GmbH (Germany) Recent Developments and Future Plans
Table 125. Cayman Chemical Company (US) Company Information, Head Office, and Major Competitors
Table 126. Cayman Chemical Company (US) Major Business
Table 127. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 128. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Cayman Chemical Company (US) Recent Developments and Future Plans
Table 130. Global Nucleic Acid Multiplex Assay Revenue (USD Million) by Players (2018-2023)
Table 131. Global Nucleic Acid Multiplex Assay Revenue Share by Players (2018-2023)
Table 132. Breakdown of Nucleic Acid Multiplex Assay by Company Type (Tier 1, Tier 2, and Tier 3)
Table 133. Market Position of Players in Nucleic Acid Multiplex Assay, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 134. Head Office of Key Nucleic Acid Multiplex Assay Players
Table 135. Nucleic Acid Multiplex Assay Market: Company Product Type Footprint
Table 136. Nucleic Acid Multiplex Assay Market: Company Product Application Footprint
Table 137. Nucleic Acid Multiplex Assay New Market Entrants and Barriers to Market Entry
Table 138. Nucleic Acid Multiplex Assay Mergers, Acquisition, Agreements, and Collaborations
Table 139. Global Nucleic Acid Multiplex Assay Consumption Value (USD Million) by Type (2018-2023)
Table 140. Global Nucleic Acid Multiplex Assay Consumption Value Share by Type (2018-2023)
Table 141. Global Nucleic Acid Multiplex Assay Consumption Value Forecast by Type (2024-2029)
Table 142. Global Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023)
Table 143. Global Nucleic Acid Multiplex Assay Consumption Value Forecast by Application (2024-2029)
Table 144. North America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 145. North America Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 146. North America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 147. North America Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 148. North America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 149. North America Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 150. Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 151. Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 152. Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 153. Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 154. Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 155. Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 156. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 157. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 158. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 159. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 160. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2023) & (USD Million)
Table 161. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2024-2029) & (USD Million)
Table 162. South America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 163. South America Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 164. South America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 165. South America Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 166. South America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 167. South America Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 168. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 169. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 170. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 171. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 172. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 173. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 174. Nucleic Acid Multiplex Assay Raw Material
Table 175. Key Suppliers of Nucleic Acid Multiplex Assay Raw Materials
Table 1. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nucleic Acid Multiplex Assay Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Nucleic Acid Multiplex Assay Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Luminex Corporation (US) Company Information, Head Office, and Major Competitors
Table 6. Luminex Corporation (US) Major Business
Table 7. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 8. Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Luminex Corporation (US) Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Inc. (US) Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc. (US) Major Business
Table 12. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 13. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Thermo Fisher Scientific Inc. (US) Recent Developments and Future Plans
Table 15. Illumina, Inc (US) Company Information, Head Office, and Major Competitors
Table 16. Illumina, Inc (US) Major Business
Table 17. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 18. Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina, Inc (US) Recent Developments and Future Plans
Table 20. Bio-Rad Laboratories, Inc. (US) Company Information, Head Office, and Major Competitors
Table 21. Bio-Rad Laboratories, Inc. (US) Major Business
Table 22. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 23. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bio-Rad Laboratories, Inc. (US) Recent Developments and Future Plans
Table 25. Qiagen N.V. (Netherlands) Company Information, Head Office, and Major Competitors
Table 26. Qiagen N.V. (Netherlands) Major Business
Table 27. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product and Solutions
Table 28. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Qiagen N.V. (Netherlands) Recent Developments and Future Plans
Table 30. Abcam plc (UK) Company Information, Head Office, and Major Competitors
Table 31. Abcam plc (UK) Major Business
Table 32. Abcam plc (UK) Nucleic Acid Multiplex Assay Product and Solutions
Table 33. Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Abcam plc (UK) Recent Developments and Future Plans
Table 35. Becton, Dickinson and Company (US) Company Information, Head Office, and Major Competitors
Table 36. Becton, Dickinson and Company (US) Major Business
Table 37. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 38. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Becton, Dickinson and Company (US) Recent Developments and Future Plans
Table 40. Merck KGaA (Germany) Company Information, Head Office, and Major Competitors
Table 41. Merck KGaA (Germany) Major Business
Table 42. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 43. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck KGaA (Germany) Recent Developments and Future Plans
Table 45. Agilent Technologies, Inc. (US) Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies, Inc. (US) Major Business
Table 47. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 48. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies, Inc. (US) Recent Developments and Future Plans
Table 50. Meso Scale Diagnostics (US) Company Information, Head Office, and Major Competitors
Table 51. Meso Scale Diagnostics (US) Major Business
Table 52. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 53. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Meso Scale Diagnostics (US) Recent Developments and Future Plans
Table 55. Randox Laboratories (UK) Company Information, Head Office, and Major Competitors
Table 56. Randox Laboratories (UK) Major Business
Table 57. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product and Solutions
Table 58. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Randox Laboratories (UK) Recent Developments and Future Plans
Table 60. Quanterix (US) Company Information, Head Office, and Major Competitors
Table 61. Quanterix (US) Major Business
Table 62. Quanterix (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 63. Quanterix (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Quanterix (US) Recent Developments and Future Plans
Table 65. Bio-Techne Corporation (US) Company Information, Head Office, and Major Competitors
Table 66. Bio-Techne Corporation (US) Major Business
Table 67. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 68. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Bio-Techne Corporation (US) Recent Developments and Future Plans
Table 70. Olink (Sweden) Company Information, Head Office, and Major Competitors
Table 71. Olink (Sweden) Major Business
Table 72. Olink (Sweden) Nucleic Acid Multiplex Assay Product and Solutions
Table 73. Olink (Sweden) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Olink (Sweden) Recent Developments and Future Plans
Table 75. DiaSorin S.p.A. (Italy) Company Information, Head Office, and Major Competitors
Table 76. DiaSorin S.p.A. (Italy) Major Business
Table 77. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product and Solutions
Table 78. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. DiaSorin S.p.A. (Italy) Recent Developments and Future Plans
Table 80. Seegene (South Korea) Company Information, Head Office, and Major Competitors
Table 81. Seegene (South Korea) Major Business
Table 82. Seegene (South Korea) Nucleic Acid Multiplex Assay Product and Solutions
Table 83. Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Seegene (South Korea) Recent Developments and Future Plans
Table 85. Promega Corporation (US) Company Information, Head Office, and Major Competitors
Table 86. Promega Corporation (US) Major Business
Table 87. Promega Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 88. Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Promega Corporation (US) Recent Developments and Future Plans
Table 90. Siemens Healthineers (Germany) Company Information, Head Office, and Major Competitors
Table 91. Siemens Healthineers (Germany) Major Business
Table 92. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 93. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Siemens Healthineers (Germany) Recent Developments and Future Plans
Table 95. PerkinElmer, Inc. (US) Company Information, Head Office, and Major Competitors
Table 96. PerkinElmer, Inc. (US) Major Business
Table 97. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 98. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. PerkinElmer, Inc. (US) Recent Developments and Future Plans
Table 100. Shimadzu Biotech (Japan) Company Information, Head Office, and Major Competitors
Table 101. Shimadzu Biotech (Japan) Major Business
Table 102. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product and Solutions
Table 103. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Shimadzu Biotech (Japan) Recent Developments and Future Plans
Table 105. Antigenix America, Inc. (US) Company Information, Head Office, and Major Competitors
Table 106. Antigenix America, Inc. (US) Major Business
Table 107. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 108. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Antigenix America, Inc. (US) Recent Developments and Future Plans
Table 110. Enzo Life Sciences, Inc. (US) Company Information, Head Office, and Major Competitors
Table 111. Enzo Life Sciences, Inc. (US) Major Business
Table 112. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 113. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Enzo Life Sciences, Inc. (US) Recent Developments and Future Plans
Table 115. Boster Biological Technology (US) Company Information, Head Office, and Major Competitors
Table 116. Boster Biological Technology (US) Major Business
Table 117. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 118. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Boster Biological Technology (US) Recent Developments and Future Plans
Table 120. AYOXXA Biosystems GmbH (Germany) Company Information, Head Office, and Major Competitors
Table 121. AYOXXA Biosystems GmbH (Germany) Major Business
Table 122. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product and Solutions
Table 123. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. AYOXXA Biosystems GmbH (Germany) Recent Developments and Future Plans
Table 125. Cayman Chemical Company (US) Company Information, Head Office, and Major Competitors
Table 126. Cayman Chemical Company (US) Major Business
Table 127. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product and Solutions
Table 128. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Cayman Chemical Company (US) Recent Developments and Future Plans
Table 130. Global Nucleic Acid Multiplex Assay Revenue (USD Million) by Players (2018-2023)
Table 131. Global Nucleic Acid Multiplex Assay Revenue Share by Players (2018-2023)
Table 132. Breakdown of Nucleic Acid Multiplex Assay by Company Type (Tier 1, Tier 2, and Tier 3)
Table 133. Market Position of Players in Nucleic Acid Multiplex Assay, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 134. Head Office of Key Nucleic Acid Multiplex Assay Players
Table 135. Nucleic Acid Multiplex Assay Market: Company Product Type Footprint
Table 136. Nucleic Acid Multiplex Assay Market: Company Product Application Footprint
Table 137. Nucleic Acid Multiplex Assay New Market Entrants and Barriers to Market Entry
Table 138. Nucleic Acid Multiplex Assay Mergers, Acquisition, Agreements, and Collaborations
Table 139. Global Nucleic Acid Multiplex Assay Consumption Value (USD Million) by Type (2018-2023)
Table 140. Global Nucleic Acid Multiplex Assay Consumption Value Share by Type (2018-2023)
Table 141. Global Nucleic Acid Multiplex Assay Consumption Value Forecast by Type (2024-2029)
Table 142. Global Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023)
Table 143. Global Nucleic Acid Multiplex Assay Consumption Value Forecast by Application (2024-2029)
Table 144. North America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 145. North America Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 146. North America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 147. North America Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 148. North America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 149. North America Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 150. Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 151. Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 152. Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 153. Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 154. Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 155. Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 156. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 157. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 158. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 159. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 160. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2018-2023) & (USD Million)
Table 161. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2024-2029) & (USD Million)
Table 162. South America Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 163. South America Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 164. South America Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 165. South America Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 166. South America Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 167. South America Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 168. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2018-2023) & (USD Million)
Table 169. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2024-2029) & (USD Million)
Table 170. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2018-2023) & (USD Million)
Table 171. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2024-2029) & (USD Million)
Table 172. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2018-2023) & (USD Million)
Table 173. Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2024-2029) & (USD Million)
Table 174. Nucleic Acid Multiplex Assay Raw Material
Table 175. Key Suppliers of Nucleic Acid Multiplex Assay Raw Materials
LIST OF FIGURES
Figure 1. Nucleic Acid Multiplex Assay Picture
Figure 2. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Type in 2022
Figure 4. Planar Nucleic Acid Assays
Figure 5. Bead-Based Nucleic Acid Assays
Figure 6. Other Nucleic Acid Assays
Figure 7. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Nucleic Acid Multiplex Assay Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical & Biotechnology Companies Picture
Figure 10. Hospitals & Research Institutes Picture
Figure 11. Reference Laboratories Picture
Figure 12. Other Picture
Figure 13. Global Nucleic Acid Multiplex Assay Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Nucleic Acid Multiplex Assay Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Nucleic Acid Multiplex Assay Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Region in 2022
Figure 18. North America Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Nucleic Acid Multiplex Assay Revenue Share by Players in 2022
Figure 24. Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Nucleic Acid Multiplex Assay Market Share in 2022
Figure 26. Global Top 6 Players Nucleic Acid Multiplex Assay Market Share in 2022
Figure 27. Global Nucleic Acid Multiplex Assay Consumption Value Share by Type (2018-2023)
Figure 28. Global Nucleic Acid Multiplex Assay Market Share Forecast by Type (2024-2029)
Figure 29. Global Nucleic Acid Multiplex Assay Consumption Value Share by Application (2018-2023)
Figure 30. Global Nucleic Acid Multiplex Assay Market Share Forecast by Application (2024-2029)
Figure 31. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 41. France Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Region (2018-2029)
Figure 48. China Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 51. India Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 65. Nucleic Acid Multiplex Assay Market Drivers
Figure 66. Nucleic Acid Multiplex Assay Market Restraints
Figure 67. Nucleic Acid Multiplex Assay Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Nucleic Acid Multiplex Assay in 2022
Figure 70. Manufacturing Process Analysis of Nucleic Acid Multiplex Assay
Figure 71. Nucleic Acid Multiplex Assay Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Nucleic Acid Multiplex Assay Picture
Figure 2. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Type in 2022
Figure 4. Planar Nucleic Acid Assays
Figure 5. Bead-Based Nucleic Acid Assays
Figure 6. Other Nucleic Acid Assays
Figure 7. Global Nucleic Acid Multiplex Assay Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Nucleic Acid Multiplex Assay Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical & Biotechnology Companies Picture
Figure 10. Hospitals & Research Institutes Picture
Figure 11. Reference Laboratories Picture
Figure 12. Other Picture
Figure 13. Global Nucleic Acid Multiplex Assay Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Nucleic Acid Multiplex Assay Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Nucleic Acid Multiplex Assay Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Region in 2022
Figure 18. North America Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Nucleic Acid Multiplex Assay Revenue Share by Players in 2022
Figure 24. Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Nucleic Acid Multiplex Assay Market Share in 2022
Figure 26. Global Top 6 Players Nucleic Acid Multiplex Assay Market Share in 2022
Figure 27. Global Nucleic Acid Multiplex Assay Consumption Value Share by Type (2018-2023)
Figure 28. Global Nucleic Acid Multiplex Assay Market Share Forecast by Type (2024-2029)
Figure 29. Global Nucleic Acid Multiplex Assay Consumption Value Share by Application (2018-2023)
Figure 30. Global Nucleic Acid Multiplex Assay Market Share Forecast by Application (2024-2029)
Figure 31. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 41. France Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value Market Share by Region (2018-2029)
Figure 48. China Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 51. India Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Nucleic Acid Multiplex Assay Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Nucleic Acid Multiplex Assay Consumption Value (2018-2029) & (USD Million)
Figure 65. Nucleic Acid Multiplex Assay Market Drivers
Figure 66. Nucleic Acid Multiplex Assay Market Restraints
Figure 67. Nucleic Acid Multiplex Assay Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Nucleic Acid Multiplex Assay in 2022
Figure 70. Manufacturing Process Analysis of Nucleic Acid Multiplex Assay
Figure 71. Nucleic Acid Multiplex Assay Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
